Plant-Derived Peptides: (Neglected) Natural Products for Drug Discovery^{[ # ]}

Abstract

Peptides have emerged as key regulators in various physiological processes, including growth, development, stress, and defense responses within plants as well as ecological interactions of plants with microbes and animals. Understanding and harnessing plant peptides can lead to the development of innovative strategies for crop improvement, increasing agricultural productivity, and enhancing resilience to environmental challenges such as drought, pests, and diseases. Moreover, some plant peptides have shown promise in human health applications, with potential therapeutic benefits as ingredients in herbal medicines as well as novel drug leads. The exploration of plant peptides is essential for unraveling the mysteries of plant biology and advancing peptide drug discovery. This short personal commentary provides a very brief overview about the field of plant-derived peptides and a personal word of motivation to increase the number of scientists in pharmacognosy working with these fascinating biomolecules.

Key words

Peptide - peptidomics - drug discovery

Peptides are a molecule class of growing interest to the natural products community. They have been identified and isolated from microbes, fungi, plants, and animals [1], [2]. Besides a small number of nature-derived peptides that are being enzymatically synthesized, most of them are gene derived. These so-called ribosomally synthesized and post-translationally modified peptides (RiPPs) can be discovered at the transcriptome or genome level [3]. Hence, with an ever-growing number of available genetic information, the discovery of novel peptide natural products is on the rise. For instance, the 1000 plant transcriptomes initiative (1KP) [4] and the ongoing 10 000 plant genomes sequencing project (10KP) [5] provide a unique platform of data for the discovery of RiPPs in plants. This led to studies about the biodiversity, evolution, and biosynthesis of plant-derived peptides [6], [7], as well as many exciting discoveries about their biological activity and application(s) in drug discovery [8]. This ongoing trend in plant peptide investigations is further documented by the increasing number of available databases and online collections dedicated to the curation of plant-derived peptides, such CyBase [9], PlantAFP [10], PlantPepDB [11], and PhytAMP [12].

The first plant peptide discovered was (puro)thionin from wheat in the 1940 s [13], which is a representative defense peptide found in grain seeds and many other plants [14]. The first plant peptide hormone discovered was systemin from tomatoes in 1991 [15]. Formerly, the isolation and structural characterization of these peptides must have been a laborious task, but nowadays there are multiple peptidomics workflows for fast and reliable mining of peptide sequences [1]. Over the years, several different classes of plant peptides have been described and characterized, displaying a unique diversity of sequences and three-dimensional folds ([Fig. 1]) [1], [14], [16]. It is sheer impossible to determine the exact number of existing plant peptides, but given their physiological importance, structural diversity, and kingdom-wide distribution there must be millions, most of them yet to be discovered. This provides unique opportunities for the exploration of plant peptides for biology and drug discovery.

Fig. 1 Structural diversity of plant peptides. Compilation of structural cartoons of representative members of different classes of plant-derived peptides. Exemplarily shown are: cyclotide – a cyclic knottin – from Oldenlandia affinis DC. (pdb code: 1NB1), a small cyclic trypsin inhibitor from Helianthus annuus L. (1JBL), a thionin(-like) peptide from Viscum album L. (1ED0), a defensin from Nicotiana alata Link & Otto (1MR4), an α-amylase inhibitor from Amaranthus hypochondriacus L. (1QFD), a knottin-type trypsin inhibitor from Ecballium elaterium (L.) A.Rich. (2IT7), an α-hairpinin from Hordeum vulgare L. (2M6A), a lipid transfer protein from Pisum sativum L. (2N81), a hevein-like peptide from Gypsophila vaccaria (L.) Sm. (5XDI), and orbitide (cyclic) from Jatropha ribifolia (Pohl) Baill. (6DKZ). Disulfide bonds are shown in yellow.

At a more general level, peptides appear to be ideal lead molecules for drug development since they combine the best features of “classical” small molecule drugs and “modern” biologics [17]. The number of peptide drugs approved by the US Food and Drug Administration (FDA) has steadily been growing. From 2016 to 2022, there have been 315 new drugs approved, of which 26 were peptides and 140 small molecules [18]. This equates to 8.3% of peptide drug vs. 44.4% small molecule drug approvals. Obviously, the total number of new small molecule drug approvals is still higher, but the approvals of new peptide drugs will continue to increase knowing that there are over 1000 peptides in various stages of clinical development [17], [19].

Although the quantity and structural diversity of peptides to be found in plants is unprecedented, they appear to play a subordinate role in the pharmacognosy communities as compared to small molecules. This is documented by the low number of manuscripts with “peptide-related” content that are being published, for instance, by Planta Medica, i.e., traditionally linked to the central European Pharmacognosy communities, and the leading journal of the Society for Medicinal Plant and Natural Product Research. In Planta Medica, only 0.6% of manuscripts reported a peptide or peptide-related study (i.e., 64 of a total of 10 441 manuscripts indexes in PubMed since 1961) ([Table 1]). In comparison, the Journal of Natural Products – traditionally linked to the American Chemical Society and the American Society of Pharmacognosy – published 3.4% of its manuscripts on peptide-related topics, and the Journal of Biological Chemistry even published approximately 1 in 10 papers about “peptides” ([Table 1]). Other plant-related journals, such as Phytochemistry (2.5%) and Plant Cell (3.3%), or the major interdisciplinary journal Nature (1.4%), publish at least twice to four times as many peptide papers compared to Planta Medica ([Table 1]). For reference, the Journal of Peptide Science – the official journal of the European Peptide Society – published over 86% of manuscripts about peptides, according to the search criteria as outlined in the footnotes of [Table 1].

Table 1 Numbers of published “peptide-related” articles across various journals.

Journal	Total no. articles indexed*	Period of search	“Peptide” articles#	[%]§
*Numbers are based on a PubMed (https://pubmed.ncbi.nlm.nih.gov/) search on September 5, 2023; #search term: “peptide” [Title/Abstract] OR “peptidic” [Title/Abstract] OR “peptides” [Title/Abstract] OR “peptide” [Title/Abstract]) AND “journal name” [Journal]; §calculation of percentage is based on total number of articles (including reviews); %listed as reference
Planta Medica	10 441 (incl. 398 reviews)	as of 1 961	65 (incl. 8 reviews)	0.6
Journal of Natural Products	11 832 (351)	as of 1 979	401 (24)	3.4
Phytochemistry	8 563 (500)	as of 1 991	210 (16)	2.5
Plant Cell	8 580 (298)	as of 1 989	282 (7)	3.3
Nature	130 136 (1283)	as of 1 945	1 871 (17)	1.4
Journal of Biological Chemistry	184 639 (1746)	as of 1 945	20 075 (65)	10.9
Journal of Peptide Science%	2 354 (180)	as of 1 995	2 034 (159)	86.4

Arguably, this analysis may not be representative, and there are only a few journals that were considered here. Nevertheless, the points to be made are that

• (i) peptides are fascinating molecules and display a rich biodiversity in plants,

• (ii) peptides are important molecules in drug discovery,

• (iii) the pharmacognosy community and the readership of Planta Medica are (becoming to be) experts in the isolation and characterization of bioactive molecules from plants and,

• (iv) many medicinal plants and plant species that are being extracted day by day in pharmacognosy laboratories contain peptides, yet only very few papers about peptides are being published in Planta Medica. Why?

I will not attempt to explain this discrepancy, but clearly there are missed opportunities when considering the abundance and distribution of plant peptides and availability of extraction protocols and analytical tools in many modern pharmacognosy laboratories. I have no doubt about the appreciation of plant-derived peptides by the pharmacognosy community but would like to raise awareness and spread motivation to everyone in the pharmacognosy community to consider or continue working with peptides, alongside established projects on small molecules. This could include the isolation of novel peptides with hitherto unknown biological function [20], [21], or the use of peptides as biomarkers and reference compounds for herbal quality control [22].

Examples of plant-derived peptides that have advanced into development for crop improvement or human health include the following:

• Pezadeftide, a plant-derived antifungal peptide – originally isolated from the bitterbush Picramnia pentandra – currently in clinical trials for therapy of onychomycosis or fungal nail infections (under development by Hexima, Australia) [23].

• T20K, a plant-derived circular peptide – originally isolated from the Rubiaceae Oldenlandia affinis – which is in clinical trial as a drug for multiple sclerosis (under development by Cyxone, Sweden) [24].

• Sero-X, the worldʼs first peptide-based plant extract botanical pesticide developed from the butterfly pea (Clitoria ternatea) [25] (marketed by AgInnovate, Australia).

In summary, plant peptides comprise a unique chemical space that can readily be explored using modern peptidomics tools [1] and/or phytochemistry protocols that are available to many researchers in the pharmacognosy community. Peptides of different structural classes are (underestimated) components of herbal drugs or plant-based foods or medicines such as Violae [6], Beta [7], Sambuci [26], or Visci [27]. So please spread the word, to “make peptides great (again)!”

Disclaimer

Parts of this manuscript reflect the opinion solely of the author. No offence to anyone with a different viewpoint.

Contributorsʼ Statement

C. W. G. performed the literature survey, drafted, wrote, and approved the manuscript.

Conflict of Interest

The authors declare that they have no conflict of interest.

Acknowledgements

This commentary is dedicated to the Austrian pharmacognosy community, above all to Univ. Prof. i. R. Mag. Dr. Dr.h. c. Brigitte Kopp with whom I had the pleasure of working with as a University Assistant, as well as colleagues em. o. Univ. Prof. DI Dr. Chlodwig Franz, Univ. Prof. i. R. Dr. Hermann Stuppner, and Univ. Prof. Dr. DDr.h. c. Rudolf Bauer whom I met through the pharmacognosy community and the Herbal Medicinal Products Platform Austria (HMPPA).

^# This work is dedicated to Professors Rudolf Bauer, Chlodwig Franz, Brigitte Kopp, and Hermann Stuppner for their invaluable contributions and commitment to Austrian Pharmacognosy.

• References

• 1 Hellinger R, Sigurdsson A, Wu W, Romanova EV, Li L, Sweedler JV, Sussmuth RD, Gruber CW. Peptidomics. Nat Rev Methods Primers 2023; 3: 25
• 2 Muratspahic E, Freissmuth M, Gruber CW. Nature-derived peptides: A growing niche for GPCR ligand discovery. Trends Pharmacol Sci 2019; 40: 309-326
• 3 Arnison PG, Bibb MJ, Bierbaum G, Bowers AA, Bugni TS, Bulaj G, Camarero JA, Campopiano DJ, Challis GL, Clardy J, Cotter PD, Craik DJ, Dawson M, Dittmann E, Donadio S, Dorrestein PC, Entian KD, Fischbach MA, Garavelli JS, Goransson U, Gruber CW, Haft DH, Hemscheidt TK, Hertweck C, Hill C, Horswill AR, Jaspars M, Kelly WL, Klinman JP, Kuipers OP, Link AJ, Liu W, Marahiel MA, Mitchell DA, Moll GN, Moore BS, Muller R, Nair SK, Nes IF, Norris GE, Olivera BM, Onaka H, Patchett ML, Piel J, Reaney MJ, Rebuffat S, Ross RP, Sahl HG, Schmidt EW, Selsted ME, Severinov K, Shen B, Sivonen K, Smith L, Stein T, Sussmuth RD, Tagg JR, Tang GL, Truman AW, Vederas JC, Walsh CT, Walton JD, Wenzel SC, Willey JM, van der Donk WA. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep 2013; 30: 108-160
• 4 Carpenter EJ, Matasci N, Ayyampalayam S, Wu S, Sun J, Yu J, Jimenez Vieira FR, Bowler C, Dorrell RG, Gitzendanner MA, Li L, Du W, Ullrich KK, Wickett NJ, Barkmann TJ, Barker MS, Leebens-Mack JH, Wong GK. Access to RNA-sequencing data from 1, 173 plant species: The 1000 Plant transcriptomes initiative (1KP). Gigascience 2019; 8: giz126
• 5 Cheng S, Melkonian M, Smith SA, Brockington S, Archibald JM, Delaux PM, Li FW, Melkonian B, Mavrodiev EV, Sun W, Fu Y, Yang H, Soltis DE, Graham SW, Soltis PS, Liu X, Xu X, Wong GK. 10KP: A phylodiverse genome sequencing plan. Gigascience 2018; 7: 1-9
• 6 Hellinger R, Koehbach J, Soltis DE, Carpenter EJ, Wong GK, Gruber CW. Peptidomics of circular cysteine-rich plant peptides: Analysis of the diversity of cyclotides from viola tricolor by transcriptome and proteome mining. J Proteome Res 2015; 14: 4851-4862
• 7 Retzl B, Hellinger R, Muratspahic E, Pinto MEF, Bolzani VS, Gruber CW. Discovery of a beetroot protease inhibitor to identify and classify plant-derived cystine knot peptides. J Nat Prod 2020; 83: 3305-3314
• 8 Retzl B, Zimmermann-Klemd AM, Winker M, Nicolay S, Grundemann C, Gruber CW. Exploring immune modulatory effects of cyclotide-enriched Viola tricolor preparations. Planta Med 2023; 89: 1493-1504
• 9 Wang CK, Kaas Q, Chiche L, Craik DJ. CyBase: A database of cyclic protein sequences and structures, with applications in protein discovery and engineering. Nucleic Acids Res 2008; 36: D206-D210
• 10 Tyagi A, Pankaj V, Singh S, Roy S, Semwal M, Shasany AK, Sharma A. PlantAFP: A curated database of plant-origin antifungal peptides. Amino Acids 2019; 51: 1561-1568
• 11 Das D, Jaiswal M, Khan FN, Ahamad S, Kumar S. PlantPepDB: A manually curated plant peptide database. Sci Rep 2020; 10: 2194
• 12 Hammami R, Ben Hamida J, Vergoten G, Fliss I. PhytAMP: A database dedicated to antimicrobial plant peptides. Nucleic Acids Res 2009; 37: D963-D968
• 13 Balls AK, Hale WS, Harris TH. A crystalline protein obtained from a lipoprotein of wheat flour. Cereal Chem 1942; 19: 279-288
• 14 Tam JP, Wang S, Wong KH, Tan WL. Antimicrobial peptides from plants. Pharmaceuticals (Basel) 2015; 8: 711-757
• 15 Pearce G, Strydom D, Johnson S, Ryan CA. A polypeptide from tomato leaves induces wound-inducible proteinase inhibitor proteins. Science 1991; 253: 895-897
• 16 Hellinger R, Gruber CW. Peptide-based protease inhibitors from plants. Drug Discov Today 2019; 24: 1877-1889
• 17 Muttenthaler M, King GF, Adams DJ, Alewood PF. Trends in peptide drug discovery. Nat Rev Drug Discov 2021; 20: 309-325
• 18 Al Musaimi O, Al Shaer D, Albericio F, de la Torre BG. 2022 FDA TIDES (peptides and oligonucleotides) harvest. Pharmaceuticals (Basel) 2023; 16: 336
• 19 Wang L, Wang N, Zhang W, Cheng X, Yan Z, Shao G, Wang X, Wang R, Fu C. Therapeutic peptides: Current applications and future directions. Signal Transduct Target Ther 2022; 7: 48
• 20 Grundemann C, Koehbach J, Huber R, Gruber CW. Do plant cyclotides have potential as immunosuppressant peptides?. J Nat Prod 2012; 75: 167-174
• 21 Koehbach J, OʼBrien M, Muttenthaler M, Miazzo M, Akcan M, Elliott AG, Daly NL, Harvey PJ, Arrowsmith S, Gunasekera S, Smith TJ, Wray S, Goransson U, Dawson PE, Craik DJ, Freissmuth M, Gruber CW. Oxytocic plant cyclotides as templates for peptide G protein-coupled receptor ligand design. Proc Natl Acad Sci U S A 2013; 110: 21183-21188
• 22 Huang J, Wong KH, Tay SV, How A, Tam JP. Cysteine-rich peptide fingerprinting as a general method for herbal analysis to differentiate radix astragali and radix hedysarum. Front Plant Sci 2019; 10: 973
• 23 Van der Weerden NL, McKenna J, Parisi K. Pezadeftide is a potent antifungal peptide with rapid fungicidial activity via a unique mechanism of action. J Am Acad Dermatol 2022; 87: Ab92
• 24 Gründemann C, Stenberg KG, Gruber CW. T20K: An immunomodulatory cyclotide on its way to the clinic. Int J Pept Res Ther 2019; 25: 9-13
• 25 Oguis GK, Gilding EK, Jackson MA, Craik DJ. Butterfly pea (Clitoria ternatea), a cyclotide-bearing plant with applications in agriculture and medicine. Front Plant Sci 2019; 10: 645
• 26 Alvarez CA, Barriga A, Albericio F, Romero MS, Guzman F. Identification of peptides in flowers of Sambucus nigra with antimicrobial activity against aquaculture pathogens. Molecules 2018; 23: 1033
• 27 Vergara-Barberan M, Lerma-Garcia MJ, Nicoletti M, Simo-Alfonso EF, Herrero-Martinez JM, Fasoli E, Righetti PG. Proteomic fingerprinting of mistletoe (Viscum album L.) via combinatorial peptide ligand libraries and mass spectrometry analysis. J Proteomics 2017; 164: 52-58

Publication History

Received: 06 September 2023

Accepted after revision: 21 November 2023

Article published online:
06 June 2024